A two stage clinical trial involving 48 men has demonstrated that pomegranate juice may slow the progression of prostate cancer after unsuccessful treatment. There may be implications that it can also act as a chemopreventitive agent. Story
A two stage clinical trial involving 48 men has demonstrated that pomegranate juice may slow the progression of prostate cancer after unsuccessful treatment. There may be implications that it can also act as a chemopreventitive agent. Story
